IDEX Reports Strong Q1 Results, Raises Full-Year Guidance on Organic Sales & EPS Momentum

summarizeSummary

IDEX Corporation announced robust first-quarter results, exceeding expectations with strong sales and EPS growth, and subsequently raised its full-year organic sales and adjusted EPS guidance.

check_boxKey Events

• Strong First Quarter Financial Performance

  IDEX reported Q1 2026 sales of $887 million, an increase of 9% on a reported basis and 5% organically. Reported diluted EPS rose 28% to $1.61, and adjusted diluted EPS increased 14% to $2.00. Record orders reached $988 million, up 13% reported and 10% organically.

• Full-Year Guidance Raised

  The company raised its full-year 2026 organic sales growth projection to 3% to 4%, up from previous guidance of 1% to 2%. Full-year adjusted diluted EPS guidance was also increased to a range of $8.35 to $8.55, from the prior $8.15 to $8.35.

• Continued Shareholder Returns

  IDEX returned capital to shareholders through $76 million in share repurchases during the quarter, continuing the program detailed in the 2026-02-19 10-K filing, and paid $53 million in dividends.

• Health & Science Technologies Segment Leads Growth

  The Health & Science Technologies segment was a key driver, with net sales increasing 17% and organic sales up 11%, primarily due to AI-driven demand for data center power and semiconductor markets, as well as strength in space and defense.

auto_awesomeAnalysis

IDEX Corporation delivered robust first-quarter results, surpassing expectations with significant growth in sales, EPS, and orders. The company's decision to raise its full-year organic sales and adjusted EPS guidance signals strong operational momentum and management confidence, particularly driven by performance in the Health & Science Technologies segment. This positive update, occurring while the stock trades near its 52-week high, reinforces the company's strong market position and execution. Additionally, the continued share repurchase activity demonstrates a commitment to returning capital to shareholders, further enhancing investor sentiment.